Education
About Us
Working with TipRanks
Follow Us
Sensus Healthcare, Inc. (SRTS)
NASDAQ:SRTS
Earnings Data
Report Date
Apr 30, 2026After Close (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
-0.09Last Year’s EPS
-0.16Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The call presented a mixed picture: near-term financial results for 2025 showed significant deterioration (large YoY revenue declines, margin compression, and swings to net losses and negative adjusted EBITDA), while the company highlighted a material strategic inflection—CMS granting dedicated CPT codes, a clean balance sheet ($22.1M cash, zero debt), accelerating utilization under the FDA fair deal program, international demand, and a commercial scaling plan. Management is positioning 2026 as a transition year with expectations for sequential Q1 improvement and a goal of full-year profitability, but materially adverse 2025 results and uncertainty around the lost volume from the largest customer temper the outlook.Company Guidance
New Dedicated CPT Codes for SRT and IGSRT
CMS awarded exclusive and dedicated CPT codes for SRT and IGSRT effective 01/01/2026, creating clear reimbursement for nonmelanoma skin cancer treatments and management commentary indicating a ~300% per-fraction reimbursement increase cited on the call.
Strong Balance Sheet — Cash and No Debt
Year-end cash and cash equivalents of $22.1M, unchanged from 2024, and no outstanding borrowings on the revolving credit facility, providing liquidity to fund growth and commercialization.
FDA Fair Deal Program – Rapid Usage Growth
Program ended 2025 with 18 active FDA sites and 10 pending activations; treatments in the program increased more than 8x year-over-year and number of patients treated increased by more than 250% year-over-year, demonstrating accelerating utilization and proof of concept.
Q4 Shipments and International Momentum
Shipped 14 systems in Q4 (8 U.S., 6 international, including China). Management called out international demand and margins as attractive and noted continued momentum in China, Taiwan, South Korea, and an expected Brazil regulatory clearance in 2026.
Commercial Scaling Plan and Sales Hiring
Company plans to expand the sales organization, having already added one rep and targeting 3–5 additional hires in 2026 to accelerate market education and lead conversion under the new reimbursement environment.
Inventory Build to Support Anticipated Demand
Inventories increased to $14.6M from $10.1M (up ~$4.5M, +44.6%), positioned as support for expected future system demand following reimbursement clarity.
Product and Regulatory Progress
Higher R&D investment to develop next-generation systems (R&D expense up to $7.8M from $4.2M, +85.7%), and MDSAP certification enabling broader international opportunity; management previewed Sentinel 2.0 and other product initiatives.
Guidance and Outlook
Management expects Q1 2026 system shipments to exceed Q4 2025 levels (explicitly excluding contribution from the historically largest customer) and reiterated the objective of achieving full-year profitability in 2026.
SRTS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
SRTS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 12, 2026 | $4.65 | $3.86 | -16.99% |
Nov 06, 2025 | $3.52 | $4.20 | +19.32% |
Aug 07, 2025 | $5.35 | $3.46 | -35.33% |
May 15, 2025 | $4.66 | $4.46 | -4.29% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Sensus Healthcare, Inc. (SRTS) report earnings?
Sensus Healthcare, Inc. (SRTS) is schdueled to report earning on Apr 30, 2026, After Close (Confirmed).
What is Sensus Healthcare, Inc. (SRTS) earnings time?
Sensus Healthcare, Inc. (SRTS) earnings time is at Apr 30, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SRTS EPS forecast?
SRTS EPS forecast for the fiscal quarter 2026 (Q1) is -0.09.